PMPN_Pharmaceutical & Medical Packaging News

Pharmaceutical & Medical Packaging News, October/Fall 2016

Issue link: http://dc.cn.ubm-us.com/i/736671

Contents of this Issue

Navigation

Page 13 of 35

News pmpnews.com • Pharmaceutical & Medical Packaging News Fall 2016 14 C yclic olefin copolymers from T O P A S A d v a n c e d P o l y m e r s meet the requirements of U.S. Phar- macopeia (USP) <661.1>, a new subchapter as part of Chapter <661> Plastic Packaging Systems and Their Materials of Construction, the resin maker reports. T O P A S e x p l a i n s t h a t s i x o f i t s C O C p h a r m a g r a d e s h a v e been tested and found to meet the requirements of USP <661.1> by Toxikon Corp., a leading preclinical c o n t r a c t r e s e a r c h a n d t e s t i n g organization. U S P < 6 6 1 > e n c o u r a g e s users to develop packaging with w e l l - c h a r a c t e r i z e d m a t e r i a l s . "If you have well-characterized materials, chances are you will have a well-characterized container t h a t i s s u i t a b l e f o r p a c k a g i n g pharmaceuticals," states Gunther Appel, TOPAS global product and quality manager. "You have the flexibility to assess solutions based on risk." USP <661.1> provides the testing rationale to determine whether a material is deemed well- characterized by establishing its identity, biocompatibility (biological reactivity), general physicochemical properties, additive compositions, and level of extractable metals. Appel tells PMP News that pharma packaging professionals are tasked with ensuring compliance of their p a c k a g i n g s y s t e m a s d e s c r i b e d in USP <661>: "The packaging system should adequately protect the pharmaceutical product, should be compatible with the pharmaceutical product, and should be composed of materials that are safe for use." As a result, "proving compliance of materials used in pharmaceutical pack- aging applications is the first step for them," he says. "TOPAS took this first step to enable pharma packaging pro- fessionals to start immediately with the further steps in the approval process described in USP <661.2> or other subsequent chapters of USP <661>." TOPAS COC has been used in primary pharmaceutical packag- ing (syringes, vials, containers, etc.) as well as in medical devices (insu- lin pumps and inhalers). For more details visit www.topas.com. To read more on USP Chapter <661>, see our article, "USP: 'It's your product and you know the risk—you determine the testing" at http://www. packagingdigest.com/standards/pmp- its-your-product-and-you-know-the- risk-you-determine-the-testing-160707. TOPAS COC Meets the Requirements of USP <661.1>, Reports TOPAS Advanced Polymers TOPAS COC has been used in primary pharmaceutical packaging as well as in medical devices.

Articles in this issue

Links on this page

Archives of this issue

view archives of PMPN_Pharmaceutical & Medical Packaging News - Pharmaceutical & Medical Packaging News, October/Fall 2016